Meet the LBCTrialists (non-ACE)

Description

In this session, attendees will have the opportunity to directly interact with 6 presenters of late breaking clinical trials engaging in insightful and informative conversations and having their questions answered. Implications of trials and application of their results to clinical practice will be covered.

Learning Objectives

Analyze results of LBCT presentations especially in relation to clinical implications and possible impact on clinical practice.
Evaluate the robustness of LBCT results and their applicability to patients seen in practice.
Network with leading scientists.

Session Chair(s)

Dhanunjaya Lakkireddy, MBA, MD
Sana Al-Khatib, MD, MHS

Presentation

Trial Summary: Computer Tomography-Guided Catheter Ablation for Ventricular Tachycardia. The InEurHeart multicentric randomized control trial
Presenter(s): Frederic Sacher, MD, PhD

Trial Summary: TRANSFORM-AF: Targeting Metabolic Therapy with GLP-1 Receptor Agonism for Secondary Prevention in Atrial Fibrillation
Presenter(s): Varun Sundaram

Trial Summary: 4D Phenomics-Guided Left and Right Ventricular cardiac Resynchronization Therapy Lead Placement: The MAPIT-CRT Randomized Clinical Trial
Presenter(s): Derek Chew, MD, MS

Trial Summary: Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Atrial Fibrillation Ablation: Lessons from the OPTION Trial
Presenter(s): Arwa Younis, MD

Trial Summary: Safety, Efficacy and PVI Durability of a Contact Force-Sensing Large-Tip Focal Pulsed Field Ablation Catheter Integrated With 3D Mapping to Treat Paroxysmal Atrial Fibrillation: First-in-Human Omny-IRE 3-Month Results
Presenter(s): Alexandre Almorad, MD

Trial Summary: A Multielectrode Spherical Array Pulsed Field Ablation System to Treat Paroxysmal Atrial Fibrillation: 1-Year Outcomes of the PULSAR IDE Trial
Presenter(s): Vivek Y. Reddy, MD

Disclosures

Frederic Sacher:

Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Abbott (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
inHEART (Honoraria/Speaking/Consulting Fee - Consulting)
Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

Varun Sundaram:

Nothing Relevant to Disclose

Derek Chew:

UTI Limited Partnership (Honoraria/Speaking/Consulting Fee - Independent Contractor (including contracted research))

Arwa Younis:

Nothing Relevant to Disclose

Mattias Duytschaever:

Nothing Relevant to Disclose

Vivek Reddy:

Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
Acutus Medical Inc (Stock Options – Publicly Traded - Consulting)
Affera, Inc. (Stocks – Privately Held - Consulting)
Aquaheart (Stock Options – Privately Held (including start-up companies) - Consulting)
Autonomix (Stock Options – Privately Held (including start-up companies) - Consulting)
Axon (Stock Options – Privately Held (including start-up companies) - Consulting)
BackBeat (Stock Options – Privately Held (including start-up companies) - Consulting)
Biosig Technologies, Inc. (Stock Options – Publicly Traded - Consulting)
Circa Scientific (Stock Options – Privately Held (including start-up companies) - Consulting)
Corvia Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
EpiEP (Stocks – Privately Held - Consulting)
CardioNXT (Stocks – Privately Held - Consulting)
AFTX (Stock Options – Privately Held (including start-up companies) - Consulting)
Farapulse (Stock Options – Privately Held (including start-up companies) - Consulting)
FIRE1 (Stock Options – Privately Held (including start-up companies) - Consulting)
Luxcath (Stock Options – Privately Held (including start-up companies) - Consulting)
Manual Surgical Sciences (Stocks – Privately Held - Consulting)
Medlumics (Stock Options – Privately Held (including start-up companies) - Consulting)
NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
Surecor (Stock Options – Privately Held (including start-up companies) - Consulting)
VytronUS, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
Valcare (Stock Options – Privately Held (including start-up companies) - Consulting)
CardiaCare (Stock Options – Privately Held (including start-up companies) - Consulting)
Ablacon, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
Dinova (Stock Options – Privately Held (including start-up companies) - Consulting)
Kardium (Stock Options – Privately Held (including start-up companies) - Consulting)
HRT (Stock Options – Privately Held (including start-up companies) - Consulting)
Intershunt (Stock Options – Privately Held (including start-up companies) - Consulting)
AtaCor Medical Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
Sirona Medical Technologies, Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
CoreMap (Honoraria/Speaking/Consulting Fee - Consulting)
Corisma Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
Restore Medical (Stocks – Privately Held - Consulting)
VIZARAmed (Stocks – Privately Held - Consulting)
Anumana (Stock Options – Privately Held (including start-up companies) - Consulting)
APN Health (Stock Options – Privately Held (including start-up companies) - Consulting)
EP Frontiers (Stock Options – Privately Held (including start-up companies) - Consulting)
Field Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
Focused Therapeutics (Stock Options – Privately Held (including start-up companies) - Consulting)
Javelin (Stock Options – Privately Held (including start-up companies) - Consulting)
Oracle Health (Stock Options – Privately Held (including start-up companies) - Consulting)
Soundcath (Stocks – Privately Held - Consulting)
Abbott Medical (Honoraria/Speaking/Consulting Fee - Consulting)
Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Atrian Medical Ltd. (Honoraria/Speaking/Consulting Fee - Consulting)
BioTel (Honoraria/Speaking/Consulting Fee - Consulting)
Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
Cairdac (Honoraria/Speaking/Consulting Fee - Consulting)
CardioFocus, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
W.L. Gore & Associates (Honoraria/Speaking/Consulting Fee - Consulting)
Impulse Dynamics USA (Honoraria/Speaking/Consulting Fee - Consulting)
Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Novo Nordisk (Honoraria/Speaking/Consulting Fee - Consulting)
Novartis (Honoraria/Speaking/Consulting Fee - Consulting)
Philips (Honoraria/Speaking/Consulting Fee - Consulting)
Pulse Biosciences (Honoraria/Speaking/Consulting Fee - Consulting)
Nyra Medical (Stocks – Privately Held - Consulting)
DRS Vascular (Stocks – Privately Held - Consulting)

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE